Navigation Links
Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA
Date:2/25/2008

MONTVALE, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Duramed Pharmaceuticals, Inc., has received notification that the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Application (NDA) for Lo SEASONIQUE(R) (levonorgestrel/ethinyl estradiol tablets 0.10 mg/0.02 mg and ethinyl estradiol tablets 0.01 mg) extended-cycle oral contraceptive. The Company is seeking approval to manufacture and market the Lo SEASONIQUE, the first lower dose, extended-cycle oral contraceptive for the prevention of pregnancy. The Prescription Drug User Fee Action (PDUFA) date for the Lo SEASONIQUE NDA is October 24, 2008.

The clinical data supporting the Lo SEASONIQUE NDA resulted from one large pivotal multi-centered, open label clinical trial which concluded in June 2007. The clinical trial involved over 2,200 female subjects between the ages of 18 and 40 at 56 sites throughout the United States. Subjects were enrolled in the clinical trial for a duration of 12 months.

Under the Lo SEASONIQUE extended-cycle regimen, women take active tablets of 0.10 mg levonorgestrel/0.02 mg of ethinyl estradiol for 84 consecutive days, followed by seven days of 0.01 mg of ethinyl estradiol. The regimen is designed to reduce the number of withdrawal bleeding periods from 13 to four per year. By contrast, the majority of oral contraceptive products currently available in the United States are based on a regimen of 21 treatment days, followed by seven days of placebo.

Important Information About Oral Contraceptives

It is estimated that more than 16 million women currently take oral contraceptives in the United States. Oral contraceptives are not for every
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
2. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
3. Nitecs IND Application for Clinical Development With Lodotra Accepted by the FDA
4. Neuralstem Shares Accepted for Trading on Amex(R)
5. Attagenes Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods
6. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
7. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
8. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
9. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
10. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
11. FDA Accepts Ranexa(R) sNDA and NDA for Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2015)... ... 25, 2015 , ... The American Brain Tumor Association announced ... Family Conference, Providing and Pursuing Answers: Advances in Research, Treatment and Care. The ... July 24-25, 2015. , “As advances in research accelerate the arrival of precision ...
(Date:6/25/2015)... , June 25, 2015  The Galien Awards Committee ... Genome Sciences and Medical Genetics at the University of ... Bono Humanum Award at the ninth annual Prix Galien ...   The Pro Bono Humanum Award recognizes ... the first woman recipient of the award.   ...
(Date:6/25/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... PTGEF,), is pleased to announce that it has completed ... approximately 36.8 million common shares at US$0.14 each. The ... closed on June 15, 2015 as per our press ... tranche closed on June 24, 2015. The Company is ...
(Date:6/25/2015)... 2015   Advaxis, Inc.  (NASDAQ: ADXS ), ... hold a business update conference call at 8:30 a.m. ... call is intended to provide Advaxis investors and stakeholders ... first half of 2015 and an overview of milestones ... 2016. A live broadcast of the conference ...
Breaking Biology Technology:Nationally Recognized Brain Tumor Experts to Speak at American Brain Tumor Association Patient and Family Conference 2The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 2The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 3Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080 2Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080 3Advaxis Provides 2015 Half-Year Review and Outlook 2Advaxis Provides 2015 Half-Year Review and Outlook 3Advaxis Provides 2015 Half-Year Review and Outlook 4Advaxis Provides 2015 Half-Year Review and Outlook 5Advaxis Provides 2015 Half-Year Review and Outlook 6Advaxis Provides 2015 Half-Year Review and Outlook 7Advaxis Provides 2015 Half-Year Review and Outlook 8
... 23 , 2012   PAREXEL International (NASDAQ: ... provider, today announced that Josef H. von Rickenbach, Chairman ... keynote address at the inaugural Massachusetts Biotechnology Council ... 2012 at Bentley University in Waltham, Massachusetts. The symposium, ...
... Keck Graduate Institute (KGI) has been selected by ... P. Sloan Foundation to administer the Professional Science Master,s ... maintaining high quality standards for PSM programs across the ... and we look forward to providing leadership for this ...
... This release is available in German . ... team from the physics department at the TUM discovered an ... a grid of magnetic eddies. Together with the team of ... the properties of these eddies, so-called skyrmions, named after the ...
Cached Biology Technology:PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium 2PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium 3PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium 4PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium 5KGI Selected to Administer PSM Affiliation Process 2Saving data in vortex structures 2
(Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
(Date:6/24/2015)... June 22, 2015 ... addition of the "Huawei Ascend Mate 7 ... to their offering. Huawei,s technological choice ... opposite direction than Apple,s and Samsung,s one. The ... developed by Fingerprint Cards, a main actor in ...
(Date:6/23/2015)... RALEIGH, N.C. , June 23, 2015 /PRNewswire/ ... technology, today announced the results of a recent ... unmatched accuracy on the wrist during activity. In ... biometric technology was compared along with the Apple ... for accurately measuring heart rate during activity. The ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... recognized climate scientist and economist Jae Edmonds will speak ... and sequestration in climate stabilization in the plenary opening ... Technologies. He is one of nearly a dozen scientists ... who will present new findings and insights to the ...
... industry and agriculture can drive soils toward a toxic ... waters, according to a new study published online in ... the Tatra Mountains of Slovakia by the University of ... the U.S. Geological Survey, shows what can happen when ...
... plants in the United States is in danger of ... cost of the requirement whether existing or anticipated ... important greenhouse gas. But an MIT analysis suggests an ... the nation to fend off growing electricity shortages using ...
Cached Biology News:PNNL leadership in carbon sequestration featured at international conference 2Acid soils in Slovakia tell somber tale 2MIT: A quicker, easier way to make coal cleaner 2MIT: A quicker, easier way to make coal cleaner 3
HybriWell seals securely to a microscope slide surface in seconds to enclose single or multiple specimens in a small reagent volume and eliminate evaporation....
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... Human IgM Assay Kit to address the ... assay for Human IgM that eliminates the ... a simple mix-and-read assay that allows the ... ng/ml in approximately 30 minutes. The Pierce ...
AC input: 230 V...
Biology Products: